Literature DB >> 23604965

Altered cytokine and BDNF levels in autism spectrum disorder.

S Ricci1, R Businaro, F Ippoliti, V R Lo Vasco, F Massoni, E Onofri, G M Troili, V Pontecorvi, M Morelli, M Rapp Ricciardi, T Archer.   

Abstract

The contribution of neuroimmune functioning and brain-derived neurotrophic factor (BDNF) to functional dysregulation in autism spectrum disorder was assessed in 29 patients under treatment in two specialized centers of Basilicata (Chiaromonte and Matera), Southern Italy, through analysis of serum levels of cytokines and BDNF. Elevated levels of the pro-inflammatory cytokine, including interleukin-1, interleukin-6, interleukin-12, interleukin-23, tumor necrosis factor-α and BDNF were observed, regardless of age and gender. Comparisons were made with age- and gender-related healthy controls. The present findings reinforce current notions regarding immunoexcitotoxic mechanisms contributing to the pathophysiology of autistic disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23604965     DOI: 10.1007/s12640-013-9393-4

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  55 in total

1.  Neuron number and size in prefrontal cortex of children with autism.

Authors:  Eric Courchesne; Peter R Mouton; Michael E Calhoun; Katerina Semendeferi; Clelia Ahrens-Barbeau; Melodie J Hallet; Cynthia Carter Barnes; Karen Pierce
Journal:  JAMA       Date:  2011-11-09       Impact factor: 56.272

Review 2.  A possible central mechanism in autism spectrum disorders, part 2: immunoexcitotoxicity.

Authors:  Russell L Blaylock
Journal:  Altern Ther Health Med       Date:  2009 Jan-Feb       Impact factor: 1.305

3.  Altered balance of proteolytic isoforms of pro-brain-derived neurotrophic factor in autism.

Authors:  Kristine L P Garcia; Guanhua Yu; Chiara Nicolini; Bernadeta Michalski; Diego J Garzon; Victor S Chiu; Enrico Tongiorgi; Peter Szatmari; Margaret Fahnestock
Journal:  J Neuropathol Exp Neurol       Date:  2012-04       Impact factor: 3.685

4.  Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac Pessah; Judy Van de Water
Journal:  Brain Behav Immun       Date:  2010-08-10       Impact factor: 7.217

5.  The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children.

Authors:  Gehan Ahmed Mostafa; Laila Yousef Al-Ayadhi
Journal:  Eur J Paediatr Neurol       Date:  2012-01-05       Impact factor: 3.140

Review 6.  Excitotoxicity in the pathogenesis of autism.

Authors:  M M Essa; N Braidy; K R Vijayan; S Subash; G J Guillemin
Journal:  Neurotox Res       Date:  2012-10-13       Impact factor: 3.911

Review 7.  Genomics and autism spectrum disorder.

Authors:  Norah L Johnson; Ellen Giarelli; Celine Lewis; Catherine E Rice
Journal:  J Nurs Scholarsh       Date:  2013-01-31       Impact factor: 3.176

8.  Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system.

Authors:  Russell L Blaylock; Joseph Maroon
Journal:  Surg Neurol Int       Date:  2012-02-15

9.  A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children.

Authors:  Gehan Ahmed Mostafa; Laila Yousef Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-06-22       Impact factor: 8.322

10.  The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism.

Authors:  Gehan A Mostafa; Laila Y Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-12-21       Impact factor: 8.322

View more
  39 in total

1.  Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation.

Authors:  Destanie R Rose; Milo Careaga; Judy Van de Water; Kim McAllister; Melissa D Bauman; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2016-11-19       Impact factor: 7.217

Review 2.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

Review 3.  Brain-Derived Neurotrophic Factor Levels in Autism: A Systematic Review and Meta-Analysis.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  J Autism Dev Disord       Date:  2017-04

Review 4.  Risk factors in autism: Thinking outside the brain.

Authors:  Lauren Matelski; Judy Van de Water
Journal:  J Autoimmun       Date:  2015-12-22       Impact factor: 7.094

5.  IFNG/IFNG-AS1 expression level balance: implications for autism spectrum disorder.

Authors:  Hamid Fallah; Arezou Sayad; Fatemeh Ranjbaran; Fatemeh Talebian; Soudeh Ghafouri-Fard; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2019-11-14       Impact factor: 3.584

Review 6.  Inflammatory profiles in the BTBR mouse: how relevant are they to autism spectrum disorders?

Authors:  Milo Careaga; Jared Schwartzer; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2014-06-14       Impact factor: 7.217

Review 7.  Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.

Authors:  A Masi; D S Quintana; N Glozier; A R Lloyd; I B Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

Review 8.  Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.

Authors:  Trevor Archer; Serafino Ricci; Danilo Garcia; Max Rapp Ricciardi
Journal:  Neurotox Res       Date:  2014-05-08       Impact factor: 3.911

9.  Meta-Analysis of BDNF Levels in Autism.

Authors:  Raluca Armeanu; Mikael Mokkonen; Bernard Crespi
Journal:  Cell Mol Neurobiol       Date:  2016-08-08       Impact factor: 5.046

10.  Elevated Serum Brain-Derived Neurotrophic Factor (BDNF) but not BDNF Gene Val66Met Polymorphism Is Associated with Autism Spectrum Disorders.

Authors:  Wei-Dong Meng; Shao-Jun Sun; Jie Yang; Rui-Xue Chu; Wenjun Tu; Qiang Liu
Journal:  Mol Neurobiol       Date:  2016-01-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.